Mergers & Acquisitions,
Civil Litigation
Jan. 21, 2022
2 firms named to lead suit over GW Pharmaceuticals merger
Federal Judge Cynthia Bashant appointed Monteverde & Associates and Kahn Swick & Foti as colead counsel for a securities class action against GW Pharmaceuticals and its board of directors, which is accused of misleading its investors during the $7.2 billion acquisition by Jazz Pharmaceuticals.
Federal Judge Cynthia Bashant appointed Monteverde & Associates PC and Kahn Swick & Foti LLC as colead counsel for a securities class action against GW Pharmaceuticals PLC and its board of directors, which is accused of misleading its investors during the $7.2 billion acquisition by Jazz Pharmaceuticals PLC.
On Tuesday, Bashant granted the motion to appoint the two ...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In
